Blood coagulation factor XIII and factor XIII deficiency

Area of Science:

• Biochemistry
• Hematology
• Genetics

Background:

• Factor XIII (FXIII) is a crucial enzyme involved in hemostasis, wound healing, and other physiological processes.
• Factor XIII deficiency (FXIIID) is a rare bleeding disorder with severe clinical manifestations, including life-threatening hemorrhages.
• Current management involves FXIII concentrates and recombinant FXIII for prophylaxis and treatment.

Purpose of the Study:

• To investigate the molecular basis of Factor XIII deficiency.
• To understand the impact of mutations on FXIII protein stability and function.
• To correlate genotype with clinical phenotype in FXIIID patients.

Main Methods:

• Molecular analysis of FXIIID patients to identify mutations.
• In vitro expression studies to assess the functional consequences of identified mutations.
• Analysis of mutation spectrum and frequency in a global patient cohort.

Main Results:

• A wide spectrum of mutations was identified in FXIIID patients, predominantly missense mutations in the FXIII-A subunit.
• Recurrent mutations were observed worldwide, suggesting potential founder effects.
• In vitro studies demonstrated that most missense mutations lead to intracellular instability of the FXIII protein, causing FXIIID.

Conclusions:

• Genetic mutations, particularly in the FXIII-A subunit, are the primary cause of FXIIID.
• Intracellular instability of the FXIII protein is a common mechanism underlying FXIIID.
• Understanding these molecular mechanisms is crucial for developing effective diagnostic and therapeutic strategies for FXIIID.